FDAFDA · Food and drugs·Recall number D-0634-2024
Gabapentin Tablets, USP, 600 mg, 500-count bottles, Rx only, Manufactured by: Granules India Limited Hyderabad-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA NDC 70010-227-05
Published August 14, 2024 · Recall initiated: July 31, 2024
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets; 3 fused tablets of Metformin ER 500 mg were found in bottle of Gabapentin Tablets
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- GABAPENTIN
- Manufacturer
- Granules Pharmaceuticals Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0370010228016
- Lot
- Lot 1380040A, Exp. date July 31, 2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.